PetMed Express Stock Analysis (NASDAQ:PETS)
PetMed Express Analysis Video
View PetMed Express stock analysis video. This is our PETS analyst opinion covering the buy and sell arguments for PETS stock.
Petmed Express Inc Stock Rating (3.5/5)
Our PetMed Express stock opinion is based on fundamentals of the company. This PetMed Express stock analysis is based on latest Q3 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.
Should you buy PETS stock?
- PetMed Express had a healthy average operating margin of 14.2% over the last 4 quarters.
- Net margins came in at average 9% for PetMed Express over the last twelve months.
- PetMed Express generates a high return on invested capital of 58.8%.
- The LTM ROE of 25.4% for PetMed Express is attractive.
Should you sell PETS stock?
- Over the last 5 years, the company registered a poor revenue growth of 0.7%.
- The company is trading at a price to sales multiple of 1.7, which is higher in comparison to the Internet Commerce industry average of 0.7, making PETS stock expensive.
- PetMed Express has a negative FCF (Free Cash Flow) margin of -0.3%.